Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers

doi:10.4251/wjgo.v16.i4.1213

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1690)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-4) series.

Item

Count

PDF

122

HTML

920

Figures (1-8)

175

Tables (1-4)

170

Sum=1387

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

202

Sum=237

Apr 15, 2024 (publication date) through Jan 11, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1213-1226
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1213

Table 2 Baseline information on laboratory tests and inflammatory markers

Characteristics [mean (SD)]	non-PVT (n = 286)	PVT (n = 286)	P value
PLT	78.93 (48.65)	70.31 (60.19)	0.06
ALB	38.50 (6.87)	35.87 (6.21)	< 0.001
PT	14.80 (3.52)	16.41 (6.53)	< 0.001
PTA	71.29 (20.97)	63.24 (15.56)	< 0.001
INR	1.30 (0.32)	1.42 (0.45)	< 0.001
D-D	1.84 (2.75)	3.75 (5.42)	< 0.001
PVD	12.86 (2.34)	14.89 (3.34)	< 0.001
SVD	8.64 (2.90)	10.43 (3.50)	< 0.001
PVV	21.08 (5.34)	19.86 (6.19)	0.012
GLR	102.36 (189.29)	78.97 (97.41)	0.064
SII	258.89 (285.64)	298.02 (473.51)	0.232
ANRI	40.18 (70.91)	27.31 (46.83)	0.011
PNI	43.51 (7.67)	39.47 (6.60)	< 0.001
NLR	3.42 (3.23)	4.04 (3.21)	0.022
PLR	92.75 (74.60)	110.43 (77.54)	0.006
ALRI	107.63 (256.37)	77.70 (66.09)	0.056

PLT: Platelet count; ALB: Albumin; PT: Prothrombin time; PTA: Prothrombin activity; INR: International normalized ratio; D-D: D-dimer; PVD: Portal vein diameter; SVD: Splenic vein diameter; PVV: Portal vein velocity; GLR: Gamma-glutamyl transpeptidase to lymphocyte count ratio; SII: Systemic immune-inflammation index; ANRI: Aspartate transaminase to neutrophil ratio index; PNI: Prognostic nutritional index; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; ALRI: Aspartate transaminase to lymphocyte ratio index; PVT: Portal vein thrombosis.

Citation: Nie GL, Yan J, Li Y, Zhang HL, Xie DN, Zhu XW, Li X. Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers. World J Gastrointest Oncol 2024; 16(4): 1213-1226
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1213.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1213